ATE309239T1 - Aminopyrrol verbindungen als entzündungshemmende wirkstoffe - Google Patents

Aminopyrrol verbindungen als entzündungshemmende wirkstoffe

Info

Publication number
ATE309239T1
ATE309239T1 AT02767427T AT02767427T ATE309239T1 AT E309239 T1 ATE309239 T1 AT E309239T1 AT 02767427 T AT02767427 T AT 02767427T AT 02767427 T AT02767427 T AT 02767427T AT E309239 T1 ATE309239 T1 AT E309239T1
Authority
AT
Austria
Prior art keywords
inflammatory actives
aminopyrrole
compounds
aminopyrrole compounds
actives
Prior art date
Application number
AT02767427T
Other languages
English (en)
Inventor
David Michael Goldstein
David Mark Rotstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE309239T1 publication Critical patent/ATE309239T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02767427T 2001-08-30 2002-08-26 Aminopyrrol verbindungen als entzündungshemmende wirkstoffe ATE309239T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31616901P 2001-08-30 2001-08-30
PCT/EP2002/009505 WO2003020715A1 (en) 2001-08-30 2002-08-26 Aminopyrrole compounds as antiinflammatory agents

Publications (1)

Publication Number Publication Date
ATE309239T1 true ATE309239T1 (de) 2005-11-15

Family

ID=23227809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02767427T ATE309239T1 (de) 2001-08-30 2002-08-26 Aminopyrrol verbindungen als entzündungshemmende wirkstoffe

Country Status (16)

Country Link
US (1) US6696471B2 (de)
EP (1) EP1423378B1 (de)
JP (1) JP2005506324A (de)
KR (1) KR20040029075A (de)
CN (1) CN1281603C (de)
AR (1) AR037140A1 (de)
AT (1) ATE309239T1 (de)
AU (1) AU2002331179B2 (de)
BR (1) BR0212077A (de)
CA (1) CA2458808A1 (de)
DE (1) DE60207273T2 (de)
ES (1) ES2252509T3 (de)
MX (1) MXPA04001810A (de)
PL (1) PL373115A1 (de)
RU (1) RU2315045C2 (de)
WO (1) WO2003020715A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2181704B1 (de) 2002-12-30 2015-05-06 Angiotech International Ag Wirkstofffreisetzung von schnell gelierender Polymerzusammensetzung
US20080113016A1 (en) * 2004-07-26 2008-05-15 Gary Steven Firestein Method for Prevention or Treatment of Inflammatory Disease
CA2681420A1 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
WO2017075274A1 (en) 2015-10-27 2017-05-04 Children's Hospital Medical Center Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and/or genetic manipulation
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
BR9710352A (pt) 1996-07-11 1999-08-17 Pfizer Compostos piridilpirrole
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
CA2329065A1 (en) 1998-05-05 1999-11-11 Francisco Xavier Talamas Pyrazole derivatives as p-38 map kinase inhibitors
WO1999058523A1 (en) * 1998-05-14 1999-11-18 G.D. Searle & Co. 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS

Also Published As

Publication number Publication date
CN1547578A (zh) 2004-11-17
MXPA04001810A (es) 2004-07-08
PL373115A1 (en) 2005-08-08
US6696471B2 (en) 2004-02-24
ES2252509T3 (es) 2006-05-16
KR20040029075A (ko) 2004-04-03
DE60207273D1 (de) 2005-12-15
EP1423378A1 (de) 2004-06-02
JP2005506324A (ja) 2005-03-03
DE60207273T2 (de) 2006-07-20
AR037140A1 (es) 2004-10-27
AU2002331179B2 (en) 2008-04-17
CA2458808A1 (en) 2003-03-13
EP1423378B1 (de) 2005-11-09
US20030130319A1 (en) 2003-07-10
BR0212077A (pt) 2004-09-28
WO2003020715A1 (en) 2003-03-13
RU2315045C2 (ru) 2008-01-20
CN1281603C (zh) 2006-10-25
RU2004109817A (ru) 2005-10-20

Similar Documents

Publication Publication Date Title
ATE549328T1 (de) Aromatisch-heterocyclische verbindungen als entzündungshemmende mittel
ATE423120T1 (de) Pyrroloä2,3-düpyrimidin verbindungen als immunosuppressive wirkstoffe
ATE447565T1 (de) Spiro-hydantoin-verbindungen, die sich als entzündungshemmende mittel eignen
ATE299875T1 (de) Benzoamid-piperidin verbindungen als substanz p- antagonisten
EE200100483A (et) Põletikuvastaste vahenditena kasutatavad ühendid
EP1296698A4 (de) Therapeutische verbindungen
DE60210782D1 (de) Glukokinase beeinflussende verbindungen
NO20026253L (no) Organiske forbindelser
ATE549329T1 (de) Chinazoline verbindungen
EP1333834A4 (de) Antiphlogistische mittel
ATE414705T1 (de) Entzündungshemmende di- und trifluortriazolopyridin-verbindungen
ATE323674T1 (de) Orale antidiabetische wirkstoffe
DE50206096D1 (de) Substituierte benzoäbüazepin-2-on-verbindungen als schmerzmittel
ATE309239T1 (de) Aminopyrrol verbindungen als entzündungshemmende wirkstoffe
DE60228478D1 (de) Aryl-annellierte azapolyzyklische verbindungen
ATE380177T1 (de) Kalzilytische verbindungen
EP1490040A4 (de) Entzündungshemmende formulierungen
FI20002525A7 (fi) Tulehduksenvastaisia aineita
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
SE0101239D0 (sv) Pharmaceutically useful compounds
SE0002921D0 (sv) Pharmaceutically useful compounds
SE0004458D0 (sv) Pharmaceutically useful compounds
SE0002922D0 (sv) Pharmaceutically useful compounds
DK1341539T3 (da) Antiinflammatoriske midler
SE0003368D0 (sv) Therapeutic compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1423378

Country of ref document: EP

REN Ceased due to non-payment of the annual fee